Valproate dispensing safety — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Refer urgently to the prescriber or specialist and discuss pregnancy testing and risk
Valproate is associated with major teratogenic and neurodevelopmental risks. Possible pregnancy and absence of contraception require urgent clinical review, but abrupt stopping may destabilise epilepsy or bipolar disorder and should be specialist-led. The pharmacist should ensure warning materials and safeguarding advice are addressed.
Reference: BNF; MHRA Drug Safety Update